Welcome to Biocellerex
Biocellerex was founded by Mr. Greg Pilant. Mr. Pilant also founded Greystone Pharmaceuticals, Inc. Both companies primarily focus on developing new medical technologies. Mr. Pilant’s newest compound is a broadly-enabling, patent-pending technology which down-regulates the production of matrix metalloproteases, or MMPs, which are known to cause up to 80% of chronic wounds. This unique formulation is trademarked QBx™ and is the active ingredient in Accelerex.™
This product is highly efficacious in the treatment of the following indications: